Montgomery Pamela W. 4

What Happened Pamela W. Montgomery, Chief Legal Officer — Healthcare at Nutex Health (NUTX), reported two transactions. On 2026-03-13 she acquired 79 shares in a purchase at $88.87 per share for a total of $7,021. She also reported an exercise/conversion of 1,523 derivative shares (code M) on 2026-03-10 at $0.00, reflecting receipt of shares from a derivative award (likely RSUs).

Key Details

• Transaction dates and prices:
  • 2026-03-13: Purchase (code P) — 79 shares at $88.87, total $7,021.
  • 2026-03-10: Exercise/conversion (code M) — 1,523 shares at $0.00 (derivative acquisition).
• Shares owned after transaction: Not specified in the excerpt of the filing provided.
• Footnote: This Form 4 corrects the number of restricted stock units (RSUs) beneficially owned following the RSU grant reported in the Form 4 filed March 10, 2026.
• Filing date: Form filed 2026-03-16 covering transactions through 2026-03-13 (no late‑filing flag indicated).

Context The purchase (code P) is a small open-market/private buy ($7k), which is more informative to investors than routine sales but is modest in size. The March 10 activity (code M, $0 exercise) represents receipt of shares through exercise or conversion of a derivative award—commonly RSU vesting or conversion—not an immediate cash sale. The filing corrects prior RSU reporting; it does not by itself indicate the insider’s motive.